TO
Trustees of the University of Pennsylvania
13F filer · CIK 0000351083Reported Aug 10, 2026
Net seller this quarter
13F portfolio value$104MU.S. long equity reported on 13F
Positions52 new · 1 closed
Net flow last quarter-$175MBuys minus sells
Top 10 positions weight100.0%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 10, 20265 positions | |||||
| $82.5M | 79.14% | 1.25% | -15.4% | Q4 2025 | |
| $10.6M | 10.21% | 0.20% | -89.8% | Q1 2026 | |
| $7.1M | 6.81% | Not reported | New | Q2 2026 | |
| $3.85M | 3.69% | 0.21% | -94.5% | Q3 2023 | |
| $151K | 0.15% | 0.01% | New | Q2 2026 | |
| Q1 2026Reported May 14, 20264 positions | |||||
| $156M | 52.65% | 1.47% | Not reported | Q4 2025 | |
| $73.5M | 24.75% | 2.23% | New | Q1 2026 | |
| $60.3M | 20.30% | 3.86% | Not reported | Q3 2023 | |
| $6.81M | 2.29% | 1.17% | Not reported | Q4 2021 | |
| Q4 2025Reported Feb 6, 20263 positions | |||||
| $143M | 70.16% | 1.48% | New | Q4 2025 | |
| $52.7M | 25.87% | 3.86% | +381.0% | Q3 2023 | |
| $8.08M | 3.97% | 1.17% | Not reported | Q4 2021 | |
| Q3 2024Reported Nov 14, 20243 positions | |||||
| $21.6M | 76.40% | 1.18% | Not reported | Q4 2021 | |
| $5.43M | 19.24% | 0.80% | Not reported | Q3 2023 | |
| CTCARMCarisma Therapeutics Inc. | $1.23M | 4.36% | 3.00% | Not reported | Q1 2023 |
Premium opens every quarter this fund has filed